The Board of Pharmacy announced a rulemaking hearing on July 26 and is proposing to adopt the following rules. The rulemaking hearing will be held virtually and begins at 9:30 a.m. If you plan to testify, please complete the sign-up form on the website. Written comments may be submitted by 4:30 p.m. on July 26 via email.
- Division 080 related to Schedule I – Xylazine
- Division 102 related to Board Administration
- Division 104 related to Universal Rules
- Division 115 related to Pharmacists
- Division 120 related to Interns and Preceptors
- Division 125 related to Pharmacy Technicians
Also in Oregon, the Board of Pharmacy announced it will receive public comments on the following proposed compounding rules at the July 26 rulemaking hearing beginning at 9:30 a.m. If you plan to testify or submit written comments, see the above section for guidance.
- Divisions 041/043/183 related to Drug Compounding (Please note: the board does not intend to adopt these rules in August 2023; It is only seeking public comment.)
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.